A new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.
Pamela B. Landsman-Blumberg, DrPH, MPH
Advertisement
Articles by Pamela B. Landsman-Blumberg, DrPH, MPH
Advertisement
Latest Updated Articles
- Adherence and Persistence of Bimatoprost in Prior Latanoprost Users
Published: December 14th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms
5
